Molecular profile
- Molecular Formula
- C 188 H 293 N 53 O 44 S
- Molecular Weight
- 4031.7 g/mol
Peptide research profile
PNC-27
PNC-27 is a synthetic peptide designed for anti-cancer purposes. It functions by binding to HDM-2, thereby inhibiting its interaction with the p53 tumor suppressor protein. Studies have demonstrated that PNC-27 exhibits a selective ability to eliminate cancer cells by inducing membranolysis, which is the process of breaking down the cell membrane, ultimately leading to cell death.
Dosing literacy
Dosing & scaling, explained
The moderated mass amounts below are retained for comparison. Near-duplicates, mix-dependent volumes and device markings are excluded. This is educational source context—not a protocol or recommendation.
Recorded amount context
Mass amounts available for comparison
- Lower range200 mcgDose
Recorded example with no verified study backing; shown for amount literacy only.
- Mid range500 mcgDose
Recorded example with no verified study backing; shown for amount literacy only.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
PNC-27 Peptide
Molecular structure and properties
- 02
How Does the PNC-27 Peptide Work?
Mechanism of selective cancer cell destruction
- 03
Clinical Studies of the PNC-27 Peptide
Research outcomes in animal studies
- 04
Research on PNC-27
Scientific evidence and clinical trials
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
PNC-27 Peptide
Molecular structure and properties
- Source review pending
How Does the PNC-27 Peptide Work?
Mechanism of selective cancer cell destruction
Recorded protocol library
Amounts recorded for PNC-27
These amount records are independent from vial strength, reconstitution volume and measuring device. A recorded source is not the same as study backing, and these values are not recommendations.
- 01
Dose · lower endpoint
200 mcg
Sign in for schedule, duration and source context.
- 02
Dose · upper endpoint
500 mcg
Sign in for schedule, duration and source context.
Technical reference
Identity, limitations and unknowns
Important limitations
- Individual claims and source links have not yet completed editorial verification.
- Evidence level, applicable study model, formulation, route and population remain unassigned.
Source review
1 links awaiting verification
- Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending